Blood Coagulation Analyzers Market Outlook (2023 to 2033)

The global blood coagulation analyzers market size is likely to be valued at US$ 3,038.9 million by 2023 and is expected to reach US$ 5,680.7 million by 2033. The sales of blood coagulation Analyzers are anticipated to grow at a CAGR of 6.5% during the forecast period.

The blood coagulation Analyzers market is expected to witness remarkable growth owing to the increasing awareness of the healthcare system, surging the demand for blood coagulation analyzers in various parts of the world.

Although, risks of side effects associated with blood testing, along with the stringent regulations implemented by governments for the approval of coagulation testing devices, are estimated to hinder the demand for hemostasis analyzers. Conversely, the sales of blood coagulation Analyzers are likely to increase as manufacturers become increasingly dependent on expanding their portfolio to the e-commerce platform.

Attributes Details
Historical Value (2022) US$ 2,857.4 million
Current Year Value (2023) US$ 3,038.9 million
Expected Forecast Value (2033) US$ 5,680.7 million
Historical CAGR (2018 to 2022) 5.9%
Projected CAGR (2023 to 2033) 6.5%

Key manufacturers in the blood coagulation Analyzers market have introduced innovative analyzers that are tiny and simple to integrate, to be used in a variety of medical facilities. This is likely to spark a high demand for blood coagulation analyzers and promote market growth.

In addition, patients are able to utilize these analyzers to assess their coagulation state at the convenience of their homes. This is attributed to its ease of use and performance features, which are anticipated to bolster the sales of blood coagulation Analyzers.

Numerous studies have found a connection between increased d-timer and t-PA antigen levels and the risk of coronary heart disease (CHD). This is likely to significantly drive market growth and surge the demand for hemostasis testing.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Factors Driving the Blood Coagulation Analyzers Market on a Global Level

Attributes Details
Rise in Cardiovascular Diseases with Underlying Obesity Cardiovascular illnesses and blood disorders have been increasing in the population. This is expected to be the most pivotal aspect driving the blood coagulation analyzers market growth. Severe blood-related illnesses can be a burden to treat as healthcare costs are rising progressively. Furthermore, there has been significant growth in the geriatric population. These factors are likely to significantly contribute to expanding the blood coagulation analyzers market size.
Improved Accuracy of Analyzers Technological developments in blood coagulation testing have made the process easier, more detailed, and more accurate. Rising obesity rates require extensive blood coagulation testing to determine blood sugar levels. The demand for blood coagulation analyzers is anticipated to witness massive growth owing to these drivers.
Innovation in the Healthcare Industry There has been an increase in the proliferation of innovative healthcare facilities, laboratory facilities, treatment centers, and academic institutions as a result of the growing sales of blood coagulation analyzers. These factors are estimated to accelerate market growth during the forecast period.

Challenges in the Blood Coagulation Analyzers Market

The blood coagulation analyzers market is likely to experience a restriction in growth due to the high cost of fully mechanical coagulation analyzers. Furthermore, the slow adoption of sophisticated hemostasis procedures in emerging and developing economies is further expected to obstruct the blood coagulation analyzers' market size.

Growth Opportunities in the Blood Coagulation Analyzers Market

  • The launch of new coagulation analyzer tests, along with rapid technological advancements have increased the efficiency and quality of hemostasis laboratories. This is because these advanced coagulators have high throughput, reliability, and adaptability, as well as precision, accuracy, and easy-to-use software with built-in graphs and calibration curves.
  • The growing awareness of the risks of cardiovascular diseases, obesity, and hypertension is compelling people to assemble at hospitals and health facilities for routine blood tests. This is expected to aid in the blood coagulation analyzers market expansion and inspires manufacturers to develop better and faster testing methods.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

How is the Performance of the North America Blood Coagulation Analyzers Market?

With an adequate revenue of 37.0%, North America holds the largest share of the blood coagulation Analyzers market. This is attributed to the highly favorable healthcare resources associated with the increasing prevalence of cardiometabolic disorders.

The growing prevalence of chronic, as well as increasing laboratory automation in this region, is likely to fuel the sales of blood coagulation analyzers. Additionally, the implementation of strategic initiatives by the top market players in this region is further expected to contribute to the global blood coagulation analyzers market expansion.

What is the Europe Blood Coagulation Analyzers Market Outlook?

Europe is the second largest blood coagulation analyzer market with a revenue of 28.6%. This is owing to the rapid launches of anti-coagulants.

Blood clotting issues are increasing in occurrence in this region, which effectuates the requirement for hemostasis. Furthermore, manufacturers of this region are coming up with new innovations as consumers demand for blood coagulation analyzers.

The Asia-Pacific blood coagulation analyzers market is growing at a considerable rate owing to the growing geriatric population, as well as the increasing prevalence of blood disorders.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Analysis

Countries 2022 Value Share in Global Market
United States 33.5%
Germany 6.6%
Japan 6.4%

Are Blood Coagulation Analyzers the Key to Personalized Hemostasis Treatment in the United States?

The United States blood coagulation analyzers market is poised for substantial growth due to the increasing prevalence of hemostasis disorders. The United States has witnessed a rising prevalence of hemostasis disorders, such as deep vein thrombosis (DVT), pulmonary embolism (PE), and clotting factor deficiencies. According to the American Cancer Society (ACS), around 21,250 new cases of chronic lymphocytic leukemia (CLL) were reported in the United States in 2021. The disease is diagnosed by analyzing modified blood cells affected by leukemia. This trend is driving the demand for blood coagulation analyzers in both clinical and research settings. The United States is at the forefront of personalized medicine initiatives. In the context of blood coagulation analyzers, this trend translates into tailored treatment plans based on individual patients' coagulation profiles. The emphasis on personalized medicine is driving the adoption of sophisticated coagulation analyzers capable of detailed and comprehensive assessments.

Are Blood Coagulation Analyzers in Germany Transforming Point-of-care Testing?

The Germany blood coagulation analyzers market is poised for growth due to an increasing prevalence of coagulation disorders, technological advancements, and a favorable regulatory landscape. Germany is witnessing an increase in the number of patients with coagulation disorders, such as hemophilia and deep vein thrombosis, due to factors like an aging population and sedentary lifestyles. Germany has a robust research ecosystem, with academic institutions and medical centers collaborating with manufacturers to develop cutting-edge coagulation analyzers and diagnostic techniques. The German healthcare system is increasingly adopting personalized medicine approaches, leading to tailored treatment plans for patients with coagulation disorders.

Is Japan's Aging Population Driving Demand for Blood Coagulation Analyzers?

The Japan blood coagulation analyzers market has been experiencing steady growth over the past few years due to the increasing prevalence of bleeding disorders and the rising elderly population. Japan is known for its technological prowess, and this is reflected in the medical field, including blood coagulation analyzers. Japan has one of the world's highest aging populations, which is prone to coagulation disorders and requires regular monitoring. This demographic factor fuels demand for blood coagulation analyzers and related consumables. Japan faces a significant burden of viral hepatitis, which can lead to liver damage and coagulation disorders. Blood coagulation analyzers play a crucial role in monitoring patients with viral hepatitis undergoing antiviral therapy.

Countries Value CAGR (2023 to 2033)
United Kingdom 7.8%
China 7.6%
India 7.1%

Are Handheld Point-of-Care Blood Coagulation Analyzers the Future of United Kingdom Healthcare?

The United Kingdom's aging population and lifestyle factors have contributed to the increasing prevalence of hemostatic disorders. This has driven the demand for blood coagulation analyzers in both clinical laboratories and point-of-care settings. The healthcare sector's shift towards personalized medicine has impacted the United Kingdom blood coagulation analyzers market. There is a growing need for analyzers that offer tailored treatment plans based on individual patient profiles and genetic makeup. Point-of-care testing devices, including handheld coagulation analyzers, are gaining popularity due to their ability to provide rapid results, convenience, and cost-effectiveness. This trend is likely to drive market growth, especially in primary care settings and remote areas.

How is China's Growing Medical Tourism Impacting the Demand for Coagulation Analyzers?

The China blood coagulation analyzers market has experienced significant growth in recent years due to increasing awareness of coagulation disorders, a rising aging population, and improved healthcare infrastructure. The market has witnessed the introduction of advanced coagulation analyzers capable of delivering quick and accurate results, which has fueled adoption rates among healthcare facilities. China's emergence as a medical tourism destination has increased the demand for advanced medical equipment, including blood coagulation analyzers, to cater to international patients. The overall growth of China's healthcare industry, including hospitals, clinics, and diagnostic centers, directly affects the demand for blood coagulation analyzers. Increasing healthcare expenditure and infrastructure development contribute to market growth.

What Role does Preventive Healthcare Play in the Rising Demand for Coagulation Analyzers in India?

India has witnessed a rise in the prevalence of bleeding disorders driven by lifestyle changes, genetic factors, and environmental conditions. This trend has boosted the demand for blood coagulation analyzers for accurate and timely diagnosis. India's healthcare expenditure has been increasing steadily, driven by government initiatives, private investments, and growing awareness of healthcare services. This growth is expected to positively impact the adoption of advanced medical equipment, including blood coagulation analyzers. With a growing emphasis on preventive healthcare, there is an increasing demand for early diagnosis and screening of coagulation disorders. The aging population in India is contributing to the increased prevalence of chronic diseases, including coagulation disorders. With the elderly population being more prone to such conditions, the demand for blood coagulation analyzers is expected to rise further.

Segment-wise Analysis

Segment 2022 Value Share in Global Market
Hospitals 58.5%
Prothrombin Time Testing 40.6%

What Sets Hospitals Apart as the Top Consumers of Blood Coagulation Analyzers?

The hospitals end user segment dominates the market since they serve a large number of patients. This leads to higher demand for blood coagulation analyzers to diagnose and monitor clotting disorders. Additionally, hospitals offer comprehensive healthcare services, including surgeries and emergency care, where the accurate clotting status determination is crucial. Specialized departments, such as hematology and coagulation laboratories, rely heavily on these analyzers for diagnosis and treatment planning. Hospital's larger budgets allow them to invest in advanced medical equipment, ensuring high-quality patient care. Skilled medical personnel within hospitals are well-trained in operating and interpreting the results of these analyzers. Moreover, hospitals often have affiliations with research and academic institutions. This makes them centers for medical advancements and research, increasing the demand for blood coagulation analyzers in this end user segment.

Are Prothrombin Time Testing Innovations Taking Over the Blood Coagulation Market?

The dominance of the prothrombin time testing segment can be attributed to its clinical importance and widespread use. Prothrombin time testing is vital for monitoring anticoagulant medication effectiveness and managing conditions like atrial fibrillation and deep vein thrombosis. Additionally, prothrombin time testing is a common test for assessing the coagulation cascade's extrinsic pathway. This makes it an integral part of coagulation profiles. The availability of point-of-care testing has further boosted its adoption in various healthcare settings. Regulatory approval, continuous research and development, cost-effectiveness, and well-validated methods have all contributed to the preference for prothrombin time testing systems.

Start-up Companies Contributing to the Blood Coagulation Analyzers Market Growth

The rising prevalence of cardiac diseases is surging manufacturers in the blood coagulation analyzers market to implement several strategies. These strategies are extensive research and development (R&D) activities as well as, government investments to develop improved, easy-to-use, and smoother-functioning devices.

This will help both medical facilities and patients who prefer to use these analyzers in the comfort of their own homes. Startups in the blood coagulation analyzers market, on the other hand, are tweaking the traditional techniques with a contemporary take.

  • Babson Diagnostics - They are working to improve their customers’ health by making diagnostic blood testing more convenient, accessible, and altruistic.
  • Elypta - They are developing an exceptionally accurate blood and urine test for multiple cancer indications. Elypta’s liquid biopsy platform is based on the measurement and analysis of 20 metabolites; glycosaminoglycans; tracking a vital process in cancer, etc.
  • Kalium Health - They provide real-time blood electrolyte data to transform the management of cardiorenal diseases, which affect 1 in 5 of the global population.
  • OncoHost™ - They are developing cutting-edge technology to characterize, analyze, and predict patient response to treatment, enabling personalized treatment strategies with improved outcomes & reduced side effects.
  • Drawbridge Health - By integrating engineering and proprietary chemistries, they are developing a people-friendly system for collecting and stabilizing blood samples, opening new doors to enable access to important health information.

Competitive Landscape

market growth. Ongoing research and development Research and Development activities to develop advanced technologies, as well as new product innovation further creates numerous opportunities for the blood coagulation analyzers' market share. In addition, owing to top companies along with local companies reporting to occupy the market, the competition is fierce.

Key Players of the Blood Coagulation Analyzers Market

  • F. Hoffmann-La Roche Ltd. - They are a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. They are essentially a biotechnology company that develops drugs and diagnostics to treat major diseases.
  • Sysmex Corporation - They are an integrated company, developing and manufacturing the instruments, reagents, and software needed for in vitro diagnostics and providing sales and support services to more than 190 countries and regions worldwide.
  • Siemens AG - They are a German multinational conglomerate corporation and the largest industrial manufacturing company in Europe headquartered in Munich with branch offices abroad.
  • Thermo Fisher Scientific Inc. - They are an American supplier of scientific instrumentation, reagents and consumables, and software services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006.
  • Alere Inc. - They are a global manufacturer of rapid point-of-care diagnostic tests. The company was founded in 1991 and was headquartered in Waltham, Massachusetts. As of January 2017, the company had a market capitalization of $3.47 billion with an enterprise value of $5.9 billion.

Other Market Participants of the Blood Coagulation Analyzers Market

  • Diagnostica Stago
  • NIHON KOHDEN CORPORATION
  • Helena Laboratories
  • Instrumentation Laboratory
  • International Technidyne Corporation
  • Roche Diagnostics
  • Danaher Corporation Abbott Laboratories

Recent Developments in the blood coagulation Analyzers market are

  • In July 2022, HORIBA Medical launched the latest Yumizen G800 and G1550 hemostasis analyzers, along with a range of convenient ready-to-use reagents designed for common blood coagulation tests. This expansion of their product line means that HORIBA Medical now provides a comprehensive selection of hemostasis systems and advanced reagents, catering to laboratories of all sizes and needs.
  • In October 2021, Trivitron Healthcare broadcasted the inauguration of a fresh lineup of Coagulation Analyzer products formed by Diagon Ltd. The newly introduced product line encompasses the COAG Line, featuring automated, semi-automated, and POC systems, all manufactured by Diagon Hungary. These cutting-edge systems play a crucial role in reducing bleeding risks during extensive surgeries, as well as assessing the effectiveness of hemostatic therapies and anticoagulant drugs.
  • In October 2021, Trivitron Healthcare - a medical devices company, launched a new line of Coagulation Analyzer products in India manufactured by Diagon Ltd.
  • In February 2021, Siemens Healthineers and Sysmex Corporation reported the renewal of the companies’ long-standing global supply, distributorship, sales, and service agreement for a broad portfolio of hemostasis products including a multi-year extension.
  • In December 2018, Sysmex Corporation launched the next-generation Automated Blood Coagulation Analyzers CN-6000 and CN-3000, with the aim to provide enhanced levels of productivity, reliability, and operability.
  • In August 2016, F. Hoffmann-La Roche Ltd. launched the innovative Accu-Chek Guide blood glucose monitoring system for the easy monitoring of blood glucose levels.
  • In August 2016, Siemens AG launched the Sysmex CS-2500 System, a mid-volume coagulation analyzer with an aim of expanding its product portfolio.

Key Segments Profiled in the Blood Coagulation Analyzers Market Survey

By Product :

  • Systems
  • Automated Systems
  • Semi-Automated Systems
  • Manual Systems
  • Reagents
  • Accessories

By Technology :

  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology

By Test Type :

  • Prothrombin Time Testing
  • Fibrinogen Testing
  • Activated Clotting Time Testing
  • Activated Partial Thromboplastin Time Testing
  • D-Dimer Testing
  • Platelet Function Tests
  • Anti-Factor Xa Tests
  • Heparin & Protamine Dose Response Tests for ACT

By Distribution Channels :

  • Hospitals
  • Clinical Laboratories
  • Point-of-Care Testing

By Region :

  • North America
  • Latin America
  • Asia Pacific
  • Middle East and Africa
  • Europe

Frequently Asked Questions

What is the Growth Potential of this Market?

The growth potential of this market is 6.5% through 2033

Which Region holds high Lucrativeness?

North America is projected to emerge as a lucrative market.

What Limits the Growth Potential of the Market?

High cost of fully mechanical coagulation analyzers limits the market growth.

What is North America's expected share in 2023?

North America is likely to generate 37.0% revenue in 2023

What drives sales of this market?

Innovation in the healthcare industry drives sales.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. Systems

        5.3.2. Automated Systems

        5.3.3. Semi-Automated Systems

        5.3.4. Manual Systems

        5.3.5. Reagents

        5.3.6. Accessories

    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technology

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Technology, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Technology, 2023 to 2033

        6.3.1. Optical Technology

        6.3.2. Mechanical Technology

        6.3.3. Electrochemical Technology

    6.4. Y-o-Y Growth Trend Analysis By Technology, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Test Type, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Test Type, 2023 to 2033

        7.3.1. Prothrombin Time Testing

        7.3.2. Fibrinogen Testing

        7.3.3. Activated Clotting Time Testing

        7.3.4. Activated Partial Thromboplastin Time Testing

        7.3.5. D-Dimer Testing

        7.3.6. Platelet Function Tests

        7.3.7. Anti-Factor Xa Tests

        7.3.8. Heparin & Protamine Dose Response Tests for ACT

    7.4. Y-o-Y Growth Trend Analysis By Test Type, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Test Type, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channels

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Channels, 2018 to 2022

    8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Channels, 2023 to 2033

        8.3.1. Hospitals

        8.3.2. Clinical Laboratories

        8.3.3. Point-of-Care Testing

    8.4. Y-o-Y Growth Trend Analysis By Distribution Channels, 2018 to 2022

    8.5. Absolute $ Opportunity Analysis By Distribution Channels, 2023 to 2033

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Western Europe

        9.3.4. Eastern Europe

        9.3.5. South Asia and Pacific

        9.3.6. East Asia

        9.3.7. Middle East and Africa

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. USA

            10.2.1.2. Canada

        10.2.2. By Product

        10.2.3. By Technology

        10.2.4. By Test Type

        10.2.5. By Distribution Channels

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By Technology

        10.3.4. By Test Type

        10.3.5. By Distribution Channels

    10.4. Key Takeaways

11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Product

        11.2.3. By Technology

        11.2.4. By Test Type

        11.2.5. By Distribution Channels

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Technology

        11.3.4. By Test Type

        11.3.5. By Distribution Channels

    11.4. Key Takeaways

12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. UK

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Western Europe

        12.2.2. By Product

        12.2.3. By Technology

        12.2.4. By Test Type

        12.2.5. By Distribution Channels

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Technology

        12.3.4. By Test Type

        12.3.5. By Distribution Channels

    12.4. Key Takeaways

13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. Poland

            13.2.1.2. Russia

            13.2.1.3. Czech Republic

            13.2.1.4. Romania

            13.2.1.5. Rest of Eastern Europe

        13.2.2. By Product

        13.2.3. By Technology

        13.2.4. By Test Type

        13.2.5. By Distribution Channels

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Technology

        13.3.4. By Test Type

        13.3.5. By Distribution Channels

    13.4. Key Takeaways

14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. India

            14.2.1.2. Bangladesh

            14.2.1.3. Australia

            14.2.1.4. New Zealand

            14.2.1.5. Rest of South Asia and Pacific

        14.2.2. By Product

        14.2.3. By Technology

        14.2.4. By Test Type

        14.2.5. By Distribution Channels

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By Technology

        14.3.4. By Test Type

        14.3.5. By Distribution Channels

    14.4. Key Takeaways

15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. China

            15.2.1.2. Japan

            15.2.1.3. South Korea

        15.2.2. By Product

        15.2.3. By Technology

        15.2.4. By Test Type

        15.2.5. By Distribution Channels

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product

        15.3.3. By Technology

        15.3.4. By Test Type

        15.3.5. By Distribution Channels

    15.4. Key Takeaways

16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        16.2.1. By Country

            16.2.1.1. GCC Countries

            16.2.1.2. South Africa

            16.2.1.3. Israel

            16.2.1.4. Rest of MEA

        16.2.2. By Product

        16.2.3. By Technology

        16.2.4. By Test Type

        16.2.5. By Distribution Channels

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Product

        16.3.3. By Technology

        16.3.4. By Test Type

        16.3.5. By Distribution Channels

    16.4. Key Takeaways

17. Key Countries Market Analysis

    17.1. USA

        17.1.1. Pricing Analysis

        17.1.2. Market Share Analysis, 2022

            17.1.2.1. By Product

            17.1.2.2. By Technology

            17.1.2.3. By Test Type

            17.1.2.4. By Distribution Channels

    17.2. Canada

        17.2.1. Pricing Analysis

        17.2.2. Market Share Analysis, 2022

            17.2.2.1. By Product

            17.2.2.2. By Technology

            17.2.2.3. By Test Type

            17.2.2.4. By Distribution Channels

    17.3. Brazil

        17.3.1. Pricing Analysis

        17.3.2. Market Share Analysis, 2022

            17.3.2.1. By Product

            17.3.2.2. By Technology

            17.3.2.3. By Test Type

            17.3.2.4. By Distribution Channels

    17.4. Mexico

        17.4.1. Pricing Analysis

        17.4.2. Market Share Analysis, 2022

            17.4.2.1. By Product

            17.4.2.2. By Technology

            17.4.2.3. By Test Type

            17.4.2.4. By Distribution Channels

    17.5. Germany

        17.5.1. Pricing Analysis

        17.5.2. Market Share Analysis, 2022

            17.5.2.1. By Product

            17.5.2.2. By Technology

            17.5.2.3. By Test Type

            17.5.2.4. By Distribution Channels

    17.6. UK

        17.6.1. Pricing Analysis

        17.6.2. Market Share Analysis, 2022

            17.6.2.1. By Product

            17.6.2.2. By Technology

            17.6.2.3. By Test Type

            17.6.2.4. By Distribution Channels

    17.7. France

        17.7.1. Pricing Analysis

        17.7.2. Market Share Analysis, 2022

            17.7.2.1. By Product

            17.7.2.2. By Technology

            17.7.2.3. By Test Type

            17.7.2.4. By Distribution Channels

    17.8. Spain

        17.8.1. Pricing Analysis

        17.8.2. Market Share Analysis, 2022

            17.8.2.1. By Product

            17.8.2.2. By Technology

            17.8.2.3. By Test Type

            17.8.2.4. By Distribution Channels

    17.9. Italy

        17.9.1. Pricing Analysis

        17.9.2. Market Share Analysis, 2022

            17.9.2.1. By Product

            17.9.2.2. By Technology

            17.9.2.3. By Test Type

            17.9.2.4. By Distribution Channels

    17.10. Poland

        17.10.1. Pricing Analysis

        17.10.2. Market Share Analysis, 2022

            17.10.2.1. By Product

            17.10.2.2. By Technology

            17.10.2.3. By Test Type

            17.10.2.4. By Distribution Channels

    17.11. Russia

        17.11.1. Pricing Analysis

        17.11.2. Market Share Analysis, 2022

            17.11.2.1. By Product

            17.11.2.2. By Technology

            17.11.2.3. By Test Type

            17.11.2.4. By Distribution Channels

    17.12. Czech Republic

        17.12.1. Pricing Analysis

        17.12.2. Market Share Analysis, 2022

            17.12.2.1. By Product

            17.12.2.2. By Technology

            17.12.2.3. By Test Type

            17.12.2.4. By Distribution Channels

    17.13. Romania

        17.13.1. Pricing Analysis

        17.13.2. Market Share Analysis, 2022

            17.13.2.1. By Product

            17.13.2.2. By Technology

            17.13.2.3. By Test Type

            17.13.2.4. By Distribution Channels

    17.14. India

        17.14.1. Pricing Analysis

        17.14.2. Market Share Analysis, 2022

            17.14.2.1. By Product

            17.14.2.2. By Technology

            17.14.2.3. By Test Type

            17.14.2.4. By Distribution Channels

    17.15. Bangladesh

        17.15.1. Pricing Analysis

        17.15.2. Market Share Analysis, 2022

            17.15.2.1. By Product

            17.15.2.2. By Technology

            17.15.2.3. By Test Type

            17.15.2.4. By Distribution Channels

    17.16. Australia

        17.16.1. Pricing Analysis

        17.16.2. Market Share Analysis, 2022

            17.16.2.1. By Product

            17.16.2.2. By Technology

            17.16.2.3. By Test Type

            17.16.2.4. By Distribution Channels

    17.17. New Zealand

        17.17.1. Pricing Analysis

        17.17.2. Market Share Analysis, 2022

            17.17.2.1. By Product

            17.17.2.2. By Technology

            17.17.2.3. By Test Type

            17.17.2.4. By Distribution Channels

    17.18. China

        17.18.1. Pricing Analysis

        17.18.2. Market Share Analysis, 2022

            17.18.2.1. By Product

            17.18.2.2. By Technology

            17.18.2.3. By Test Type

            17.18.2.4. By Distribution Channels

    17.19. Japan

        17.19.1. Pricing Analysis

        17.19.2. Market Share Analysis, 2022

            17.19.2.1. By Product

            17.19.2.2. By Technology

            17.19.2.3. By Test Type

            17.19.2.4. By Distribution Channels

    17.20. South Korea

        17.20.1. Pricing Analysis

        17.20.2. Market Share Analysis, 2022

            17.20.2.1. By Product

            17.20.2.2. By Technology

            17.20.2.3. By Test Type

            17.20.2.4. By Distribution Channels

    17.21. GCC Countries

        17.21.1. Pricing Analysis

        17.21.2. Market Share Analysis, 2022

            17.21.2.1. By Product

            17.21.2.2. By Technology

            17.21.2.3. By Test Type

            17.21.2.4. By Distribution Channels

    17.22. South Africa

        17.22.1. Pricing Analysis

        17.22.2. Market Share Analysis, 2022

            17.22.2.1. By Product

            17.22.2.2. By Technology

            17.22.2.3. By Test Type

            17.22.2.4. By Distribution Channels

    17.23. Israel

        17.23.1. Pricing Analysis

        17.23.2. Market Share Analysis, 2022

            17.23.2.1. By Product

            17.23.2.2. By Technology

            17.23.2.3. By Test Type

            17.23.2.4. By Distribution Channels

18. Market Structure Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Market Share Analysis of Top Players

        18.3.1. By Regional

        18.3.2. By Product

        18.3.3. By Technology

        18.3.4. By Test Type

        18.3.5. By Distribution Channels

19. Competition Analysis

    19.1. Competition Deep Dive

        19.1.1. Diagnostica Stago

            19.1.1.1. Overview

            19.1.1.2. Product Portfolio

            19.1.1.3. Profitability by Market Segments

            19.1.1.4. Sales Footprint

            19.1.1.5. Strategy Overview

                19.1.1.5.1. Marketing Strategy

                19.1.1.5.2. Product Strategy

                19.1.1.5.3. Channel Strategy

        19.1.2. NIHON KOHDEN CORPORATION

            19.1.2.1. Overview

            19.1.2.2. Product Portfolio

            19.1.2.3. Profitability by Market Segments

            19.1.2.4. Sales Footprint

            19.1.2.5. Strategy Overview

                19.1.2.5.1. Marketing Strategy

                19.1.2.5.2. Product Strategy

                19.1.2.5.3. Channel Strategy

        19.1.3. Helena Laboratories

            19.1.3.1. Overview

            19.1.3.2. Product Portfolio

            19.1.3.3. Profitability by Market Segments

            19.1.3.4. Sales Footprint

            19.1.3.5. Strategy Overview

                19.1.3.5.1. Marketing Strategy

                19.1.3.5.2. Product Strategy

                19.1.3.5.3. Channel Strategy

        19.1.4. Instrumentation Laboratory

            19.1.4.1. Overview

            19.1.4.2. Product Portfolio

            19.1.4.3. Profitability by Market Segments

            19.1.4.4. Sales Footprint

            19.1.4.5. Strategy Overview

                19.1.4.5.1. Marketing Strategy

                19.1.4.5.2. Product Strategy

                19.1.4.5.3. Channel Strategy

        19.1.5. International Technidyne Corporation

            19.1.5.1. Overview

            19.1.5.2. Product Portfolio

            19.1.5.3. Profitability by Market Segments

            19.1.5.4. Sales Footprint

            19.1.5.5. Strategy Overview

                19.1.5.5.1. Marketing Strategy

                19.1.5.5.2. Product Strategy

                19.1.5.5.3. Channel Strategy

        19.1.6. Roche Diagnostics

            19.1.6.1. Overview

            19.1.6.2. Product Portfolio

            19.1.6.3. Profitability by Market Segments

            19.1.6.4. Sales Footprint

            19.1.6.5. Strategy Overview

                19.1.6.5.1. Marketing Strategy

                19.1.6.5.2. Product Strategy

                19.1.6.5.3. Channel Strategy

        19.1.7. Danaher Corporation Abbott Laboratories

            19.1.7.1. Overview

            19.1.7.2. Product Portfolio

            19.1.7.3. Profitability by Market Segments

            19.1.7.4. Sales Footprint

            19.1.7.5. Strategy Overview

                19.1.7.5.1. Marketing Strategy

                19.1.7.5.2. Product Strategy

                19.1.7.5.3. Channel Strategy

        19.1.8. Sysmex Corporation

            19.1.8.1. Overview

            19.1.8.2. Product Portfolio

            19.1.8.3. Profitability by Market Segments

            19.1.8.4. Sales Footprint

            19.1.8.5. Strategy Overview

                19.1.8.5.1. Marketing Strategy

                19.1.8.5.2. Product Strategy

                19.1.8.5.3. Channel Strategy

        19.1.9. F. Hoffmann-La Roche Ltd.

            19.1.9.1. Overview

            19.1.9.2. Product Portfolio

            19.1.9.3. Profitability by Market Segments

            19.1.9.4. Sales Footprint

            19.1.9.5. Strategy Overview

                19.1.9.5.1. Marketing Strategy

                19.1.9.5.2. Product Strategy

                19.1.9.5.3. Channel Strategy

        19.1.10. Siemens AG

            19.1.10.1. Overview

            19.1.10.2. Product Portfolio

            19.1.10.3. Profitability by Market Segments

            19.1.10.4. Sales Footprint

            19.1.10.5. Strategy Overview

                19.1.10.5.1. Marketing Strategy

                19.1.10.5.2. Product Strategy

                19.1.10.5.3. Channel Strategy

        19.1.11. Thermo Fisher Scientific Inc.

            19.1.11.1. Overview

            19.1.11.2. Product Portfolio

            19.1.11.3. Profitability by Market Segments

            19.1.11.4. Sales Footprint

            19.1.11.5. Strategy Overview

                19.1.11.5.1. Marketing Strategy

                19.1.11.5.2. Product Strategy

                19.1.11.5.3. Channel Strategy

20. Assumptions & Acronyms Used

21. Research Methodology

Recommendations

Healthcare

Discrete Analyzers Market

July 2018

REP-GB-7026

February 2023

282 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Blood Coagulation Analyzers Market